Close Menu

lawsuit

GE Healthcare charges in its complaint that kits and instruments sold by Beckman Coulter Genomics based on the Agencourt Solid Phase Reversible Immobilization, or SPRI, technology "contain instructions to use the products in a manner that infringes one or more claims of the '231 and/or '946 patents."

CombiMatrix hopes to soon collect on a $36 million judgment in favor of the firm.

The complaint alleges breach of fiduciary duties against a number of current and ex-officials, and levels charges of insider stock trading against one of the former officials.

"The widespread use of gene sequence information as the foundation for biomedical research means that resolution of these issues will have far-reaching implications, not only for gene-based health care and the health of millions of women facing the specter of breast cancer, but also for the future course of biomedical research," the NY Southern District Court said in an opinion explaining the reasons for denying Myriad’s motion to dismiss ACLU’s challenge to its patents covering BRCA genes associated with hereditary breast and ovarian cancer.

A US district court decided this week that the lawsuit challenging the legality and constitutionality of BRCA gene patents owned by the University of Utah and exclusively licensed to Myriad has sufficient merit to be heard.

Xenomics is seeking up to $300 million in damages and the termination of its licensing deal with Sequenom.

The suit is the second that Life Tech has filed in as many weeks. It is also the second suit filed recently claiming that Illumina's Genome Analyzer infringes DNA amplification IP.

Life Technologies claims that Biosearch is infringing five patents related to fluorescent probes used in real-time PCR.

The USPTO said that since the co-assignees of the Tuschl-I IP “have divergent interests, no one side can reasonably expect or be permitted to control the prosecution of [the] patent application [at issue] to the exclusion of the others.”

Alnylam’s request to stay the suit, which was submitted jointly with the USPTO, asked the court to suspend the case until a ruling is made on an appeal in a separate but similar patent-term suit filed by Wyeth and Elan Pharma against the patent office.

Pages

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.